National Healthcare CORP Form 4 insider transactions

Robert Michael Ussery, President & COO of National Healthcare Corp, reports the grant of stock options for 15,000 shares of common stock.

Josh A. McCreary, Senior VP & General Counsel of National Healthcare Corp, reports the grant of stock options.

Brian F. Kidd, SVP and CFO of National Healthcare Corp, reports the grant of 13,500 stock options.

Timothy J. Shelly, Sr. VP Operations at National Healthcare Corp, reports the grant of stock options.

Sandra Y. Trail, a director at National Healthcare Corp, exercised stock options to acquire 1,886 shares of common stock at $69.19 per share.

James Paul Abernathy, a director at National Healthcare Corp, exercised stock options on February 20, 2025, acquiring 1,745 shares of common stock.

Timothy J. Shelly, Sr. VP Operations at National Healthcare Corp, sold 614 shares of common stock at a price of $121.44 on December 13, 2024.

An affiliate of National Health Corp sold 25,729 shares of common stock at a price of $107.8494 per share on December 31, 2024.

Robert Michael Ussery, President & COO of National Healthcare Corp, disposed of shares to cover tax obligations following the vesting of restricted stock.

CEO Stephen Flatt reports the withholding of 1,292 common stock shares to cover tax obligations after restricted stock vested on January 1, 2025.

Josh A. McCreary, Senior VP & General Counsel of National Healthcare Corp, reports a transaction involving common stock due to vested restricted stock and shares withheld for tax obligations.

Brian Kidd, SVP, Controller, and PAO of National Healthcare Corp, reports the withholding of 512 shares to cover tax obligations after restricted stock vested on January 1, 2025.

Senior VP & CIO of National Healthcare Corp, Ben Anderson Flatt, Sr., reports disposition of shares to cover tax obligations following vesting of restricted stock.

Vicki L. Dodson, a Senior VP at National Healthcare Corp, reports the withholding of shares to cover tax obligations following the vesting of restricted stock.

CEO Stephen Flatt reported gifting shares of National Healthcare Corp stock.

An affiliate of National Health Corp sold 28,147 shares of common stock at a price of $113.7082 on December 20, 2024.

National Healthcare Corp's President and COO, Robert Michael Ussery, reported a gift of 40 shares of common stock.

Director Sandra Y. Trail exercised 2,000 stock options of National Healthcare Corp at a price of $69.19 per share on December 2, 2024.

Director W. Andrew Adams distributed 2,307 shares of National HealthCare Corp common stock from a trust to beneficiaries for estate planning purposes on September 27, 2024.

Brian F. Kidd, SVP, Controller, and PAO of National Healthcare Corp, sold 2,000 shares of common stock at a price of $130.01 on September 4, 2024.

CEO Stephen Flatt of National Healthcare Corp (NHC) sold 3,907 shares of common stock on August 14, 2024.

Director James Paul Abernathy sold 1,605 shares of National HealthCare Corp stock at a price of $126.9983 on August 14, 2024.

Robert G. Adams, a director at National Healthcare Corp, exercised stock options to acquire 3,000 shares of common stock at $71.64 per share.

Josh A. McCreary, Senior VP & General Counsel of National Healthcare Corp, exercised stock options and sold shares to cover exercise price and tax obligations.

Robert Michael Ussery, President & COO of National Healthcare Corp, reports gifting shares of common stock.

Leroy E. McIntosh Jr., SVP at National HealthCare Corp, disposed of shares to cover tax obligations after restricted stock vested.

CEO Stephen F. Flatt exercised stock options and disposed of shares to cover exercise price and tax obligations, according to a recent SEC filing.

Director Robert G. Adams of National Healthcare Corp received a stock option grant on May 9, 2024, for 7,500 shares of common stock.

Director James Paul Abernathy of National Healthcare Corp. (NHC) reports the grant of stock options on May 9, 2024.

Director Richard F. LaRoche Jr. reports the grant of stock options and updates to previously reported option expiration dates.